SCHEMBL21564

SCHEMBL21564

COOP(=O)(OOC)OOC

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10365031 0.82
SCHEMBL28418661 0.82
SCHEMBL28110286 0.79
SCHEMBL27924959 0.79
SCHEMBL4800433 0.79
SCHEMBL10584165 0.79
SCHEMBL28065958 0.75 TSHR (0.63) TSHR
SCHEMBL22984169 0.72
SCHEMBL11470060 0.72
SCHEMBL18671252 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119614080-A Chromium-free zinc-aluminum coating and application thereof 国能铁路装备有限责任公司 2025-03-14 CN claimed
CN-116885279-A Lithium ion battery electrolyte additive, electrolyte and application 衢州科峰新材料有限公司 2023-10-13 CN claimed
US-8067581-B2 Biomolecules having multiple attachment moieties for binding to a substrate surface SANOFI-AVENTIS S.A. (DE) 2011-11-29 US claimed
US-20110201080-A1 BIOMOLECULES HAVING MULTIPLE ATTACHMENT MOIETIES FOR BINDING TO A SUBSTRATE SURFACE SANOFI-AVENTIS S.A. (FR) 2011-08-18 US claimed
EP-1257695-B1 BIOMOLECULES HAVING MULTIPLE ATTACHMENT MOIETIES FOR BINDING TO A SUBSTRATE SURFACE NANOGEN RECOGNOMICS GMBH (DE) 2007-03-07 EP claimed
US-7186813-B1 Biomolecules having multiple attachment moieties for binding to a substrate surface NANOGEN RECOGNOMICS GMBH (DE) 2007-03-06 US claimed
US-5891234-A Spin on glass material and method for forming a semiconductor device by using improved spin on glass material NEC CORPORATION (JP) 1999-04-06 US claimed
EP-0517548-B1 Chemical vapor deposition method for forming silicon oxide film NEC CORP (JP) 1998-09-02 EP claimed
US-4816496-A HEAT AND LIGHT RESISTANT ADHESIVES AND FILMS KABUSHIKI KAISHA TOSHIBA (JP) 1989-03-28 US claimed
US-20260027144-A1 ENTERIC CAPSULE FOR IMPROVING INTESTINAL BACTERIAL FLORA ENCAPSULATING NICOTINAMIDE MONONUCLEOTIDE TANAKA MEGUMI (JP) 2026-01-29 US disclosed
US-20250270163-A1 BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDES AND PROTEIN CONJUGATES THEREOF REGENERON PHARMA (US) 2025-08-28 US disclosed
US-20250243540-A1 PROBE RELATED REAGENTS AND METHODS BRENTANO BIOTECHNOLOGY ASSOCIATES (US) 2025-07-31 US disclosed
US-20250205266-A1 AGENT FOR ORAL DISEASES MIRAILAB BIOSCIENCE INC. (JP) 2025-06-26 US disclosed
US-12338199-B2 Bis-octahydrophenanthrene carboxamides and protein conjugates thereof REGENERON PHARMACEUTICALS, INC. (US) 2025-06-24 US disclosed
US-4560822-A ZEOLITE CATALYST, ELEVATED TEMPERATURE BASF AKTIENGESELLSCHAFT (DE) 1985-12-24 US disclosed
EP-0162385-A1 Process for the preparation of dienes by dehydration of aldehydes BASF Aktiengesellschaft (DE) 1985-11-27 EP disclosed
EP-0162387-A1 Process for the preparation of ketones by isomerization of aldehydes BASF Aktiengesellschaft (DE) 1985-11-27 EP disclosed
US-4140726-A ZEOLITE CONTAINING CESIUM, POTASSIUM OR RUBIDIUM, AND BORON OR PHOSPHORUS COMPONENT MONSANTO COMPANY (US) 1979-02-20 US disclosed
US-4115424-A TO PRODUCE STYRENE FROM TOLUENE AND METHANOL MONSANTO COMPANY (US) 1978-09-19 US disclosed
US-3953539-A PHOSPHORUS COMPOUNDS TEIJIN LTD. (JA) 1976-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027144-A1 ENTERIC CAPSULE FOR IMPROVING INTESTINAL BACTERIAL FLORA ENCAPSULATING NICOTINAMIDE MONONUCLEOTIDE SI, SIRT1, NNT TSHR 4693/4885
US-12338199-B2 Bis-octahydrophenanthrene carboxamides and protein conjugates thereof NR1H4, NR1H3, OGFR TSHR 134/4885
US-20250205266-A1 AGENT FOR ORAL DISEASES NAMPT, NNT, NAPRT TSHR 4421/4885
US-20110201080-A1 BIOMOLECULES HAVING MULTIPLE ATTACHMENT MOIETIES FOR BINDING TO A SUBSTRATE SURFACE RNGTT, PNKP, MTAP TSHR 2978/4885
US-20250270163-A1 BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDES AND PROTEIN CONJUGATES THEREOF NR1H4, NR1H3, OGFR TSHR 134/4885
US-20250243540-A1 PROBE RELATED REAGENTS AND METHODS DNTT, NCL, NT5C3B TSHR 2288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.